https://www.selleckchem.com/pr....oducts/rbn013209.htm
2, 95% CI (1.4-7.3), p=0.005]. Additionally, age 60 years was associated with an increased risk of hyperkalemia when compared to younger age group 18-39 years [adjusted OR 6.5, 95% CI (2.1-19.7); p=0.001]. Co-trimoxazole use is associated with high incidence of hyperkalemia, especially among older patients and those receiving it in combination with other medications that might contribute to hyperkalemia development such as calcineurin inhibitors and β-blockers. Co-trimoxazole use is associated with high incidence of hyperkalemia,